In a case series of six patients with refractory lupus nephritis who were treated off-label with an anti-CD38 monoclonal antibody, five patients achieved complete or partial renal responses by 12 months of follow-up.
- Dario Roccatello
- Roberta Fenoglio
- Savino Sciascia
